HDAC6 and neoplasm: Although medulloblastoma tumors showed increased HDAC6 expression and activity that was accompanied by reduced tubulin acetylation, the HDAC6-specific inhibitor tubastatin A did not show anti-tumor activity under our experimental conditions.